Keywords: watson, presents, safety, data, silodosin, usa, pharmaceuticals

Watson presents safety data on silodosin

Article | 06 October 2008

The USA's Watson Pharmaceuticals presented efficacy and safety data on Rapaflo (silodosin), its investigational treatment for benign prostatic hyperplasia, at ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Watson Pharmaceuticals

Go to company listing